Drugs / FSH-CTP
FSH-CTP
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02757287 | May 2016 → Nov 2017 | infertility disorder | Fundacion Dexeus | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FSH-CTP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02757287 ↗ |
| Known as | corifollitropin alfa | “There is a preparation of long-acting recombinant follicle stimulating hormone (rFSH= (corifollitropin alfa (FSH-CTP), Elonva®, MSD), that allows that a single subcutaneous...” NCT02757287 ↗ |
| Known as | Elonva | “There is a preparation of long-acting recombinant follicle stimulating hormone (rFSH= (corifollitropin alfa (FSH-CTP), Elonva®, MSD), that allows that a single subcutaneous...” NCT02757287 ↗ |
| Modality | Protein / enzyme biologic | “long-acting recombinant follicle stimulating hormone” NCT02757287 ↗ |
| Route | Subcutaneous | “single subcutaneous injection” NCT02757287 ↗ |